Sign Up for Our Newsletter
Contact Donate

Idiopathic Thrombocytopenic Purpura

Program Status

 

Fully Allocated – We are no longer accepting or processing applications for new or renewal patients.

Maximum Award Level

$3,000 per year

Eligibility Criteria

Patient must have Medicare insurance coverage.
The medication must treat the disease directly.
Patient must reside and receive treatment in the United States.
Patient’s income must fall below 400% of the Federal Poverty Level.

Get Help With Your Treatment

Apply Online (Click Here) or call 1-866-316-PANF (7263)

Information About the Disease

Idiopathic thrombocytopenic purpura (ITP), also called immune thrombocytopenic purpura, is a blood-clotting disorder that can lead to easy or excessive bruising and bleeding. ITP results from unusually low levels of platelets.

ITP affects both children and adults. Children often develop idiopathic thrombocytopenic purpura after a viral infection and usually recover fully without treatment. In adults, however, the disorder is often chronic.

For more information about ITP, visit the National Heart Lung and Blood Institute's website.